Career history of Carolyn Finkle
Former positions of Carolyn Finkle
| Companies | Position | Start | End |
|---|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | General Counsel | 13/03/2022 | 26/12/2023 |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Chief Operating Officer | 31/12/2018 | 31/12/2020 |
| General Counsel | 31/12/2018 | 31/12/2020 | |
| PRECIGEN, INC. | General Counsel | - | - |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| IMUNON, INC. | General Counsel | - | - |
Training of Carolyn Finkle
| University of Ottawa | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Statistics
International
| United States | 5 |
| Canada | 4 |
Operational
| General Counsel | 4 |
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| IMUNON, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Stock Market
- Insiders
- Carolyn Finkle
- Experience
